CIK: 0001372218 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 16, 2021
Total Value ($000): $604,878 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | REATA PHARMACEUTICALS INC | 2,896,901 | $409,998 | 67.8% | $31.64 | — | CL A | 75615P103 |
| — | INSTIL BIO INC | 8,478,790 | $163,810 | 27.1% | $25.08 | — | COM | 45783C101 |
| — | APOLLO ENDOSURGERY INC | 3,169,845 | $25,676 | 4.2% | $3.34 | — | COM | 03767D108 |
| QQQ | INVESCO QQQ TR | 15,219 | $5,394 | 0.9% | $288.49 | — | UNIT SER 1 | 46090E103 |